Intas closing in on Mallinckrodt ’s US generics business

This comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themselves under scrutiny.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news